Head-to-head · Cost-Efficiency Index
Medical Health Institute vs MadeMed
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Medical Health Institute
Shoppers comparing across TRT, peptides, and weight loss under one provider who don't need public pricing detail up front.
Visit Medical Health InstituteMadeMed
Shoppers comfortable paying three months at a time who want one flat price at every dose, or a no-needle sublingual semaglutide tablet.
Visit MadeMedThe verdict
Medical Health Institute and MadeMed tie on the Cost-Efficiency Index at 68/100, so neither wins outright on the numbers, so choose on fit. Medical Health Institute: Shoppers comparing across TRT, peptides, and weight loss under one provider who don't need public pricing detail up front. MadeMed: Shoppers comfortable paying three months at a time who want one flat price at every dose, or a no-needle sublingual semaglutide tablet.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Medical Health Institute.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Medical Health Institute | MadeMed |
|---|---|---|
| Cost-Efficiency Index | 68/100 | 68/100 |
| Semaglutide / mo | $100/moAll doses, compounded | $239/moQuarterly plan, billed $717 every 3 months, same price at every dose, compounded |
| Tirzepatide / mo | Not disclosed | $399/moQuarterly plan, billed $1,197 every 3 months, same price at every dose, compounded |
| Semaglutide / yr (modeled) | $1,200 | $2,868 |
| Tirzepatide / yr (modeled) | — | $4,788 |
| Coverage | Coverage not published | 23 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #156 | #161 |
Medical Health Institute
68/100Where the value is
- Advertises a competitively low $100/mo entry price for GLP-1 weight loss
- Offers multiple service lines (weight loss, TRT, peptide therapy) under one provider
- LegitScript and HIPAA-compliance badges both displayed on the homepage
The tradeoffs
- The $100/mo headline price carries the company's own asterisk — '*Based on pharmacy availability' — meaning it is explicitly not a guaranteed rate before intake
- No dose tier or even which drug (semaglutide vs. tirzepatide) the $100 figure applies to is disclosed anywhere public
MadeMed
68/100Where the value is
- One flat price at every dose, printed dose by dose on each product page
- Offers sublingual semaglutide tablets ($219 a month quarterly) and oral tirzepatide alongside the injections
- You can cancel or pause in one click from your dashboard, and it emails you 7 days before every charge
The tradeoffs
- There is no monthly plan; the shortest commitment is three months, billed up front
- Injectable semaglutide is offered in only 23 states, fewer than the 40 the service lists overall, so check your state on the product page
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.